🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

11 recruiting trials

for Steroid-Refractory Acute Graft-Versus-Host Disease

Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD NCT07364617Phase 21 site📍 Taoyuan Chang Gung Memorial Hospital · Tests: Fecal microbiota transplantation (FMT) Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHD NCT07184853NA1 site📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: Ruxolitinib (JAKAVI®), Etanercept (Enbrel) Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy NCT04629833Phase 342 sites📍 Amiens📍 Besançon📍 Grenoble medac GmbH · Tests: MC0518, BAT Comparison of Medical RESCUE Strategies for Patients With Steroid-refractory Acute Severe Ulcerative Colitis NCT06660693Phase 31 site📍 Hamilton McMaster University · Tests: Upadacitinib Oral Product Study of Standardized Withaferin-A for the Treatment of Steroid Refractory Acute Graft Versus Host Disease. NCT07708987Phase 21 site📍 Navi Mumbai Tata Memorial Centre · Tests: Standardized Withaferin A (SWA) Universal CNK-UT Therapy for Refractory aGVHD NCT06750133Phase 12 sites📍 Fuzhou📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: Chimeric Natural Killer Receptor Universal T-cells (CNK-UT) Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease NCT04744116EARLY Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Cellular Therapy, Ruxolitinib A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD NCT06321198NA1 site📍 Hefei Anhui Provincial Hospital · Tests: iMSC Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease NCT06343792Phase 211 sites📍 Duarte📍 Los Angeles📍 Atlanta ReAlta Life Sciences, Inc. · Tests: RLS-0071 Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation NCT07572669Phase 21 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: Moxibustion, Moxibustion Twice Daily Plus Best Available Treatment (BID Group), Best Available Treatment (BAT) FMT for Pediatric SR-aGVHD NCT07602751Phase 1, Phase 23 sites📍 Bologna📍 Padova📍 Roma Bambino Gesù Hospital and Research Institute · Tests: Fecal Microbial Transplantation
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy